The Outcome of High-Dose Corticosteroid Treatment Among Coronavirus Disease 2019 Patients A Retrospective Cohort Study

被引:0
作者
Icten, Sacit [1 ]
Ergen, Pinar [2 ]
Aydin, Ozlem [2 ]
Inal, Ferda Yilmaz [3 ]
Koruk, Senem [3 ]
Pamukcu, Muge Nural [3 ]
Eken, Erhan [4 ]
Uzunlulu, Mehmet [4 ]
Kocoglu, Hasan [3 ]
Arslan, Ferhat [2 ]
Vahaboglu, Haluk [2 ]
机构
[1] Istanbul Medeniyet Univ, Gogus Hastaliklari, Istanbul, Turkey
[2] Istanbul Medeniyet Univ, Enfeksiyon Hastaliklari & Klin Mikrobiyol Anabili, Istanbul, Turkey
[3] Istanbul Medeniyet Univ, Anestezi & Reanimasyon, Istanbul, Turkey
[4] Istanbul Medeniyet Univ, Ic Hastaliklari, Istanbul, Turkey
关键词
corticosteroids; prednisolone; propensity score; COVID-19; IMMUNITY;
D O I
10.1097/IPC.0000000000001152
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
This study aimed to demonstrate the association between high-dose corticosteroid administration and adverse outcomes in coronavirus disease 2019 patients. Data were collected retrospectively from medical records. The primary outcome was invasive mechanical ventilation or death, whichever occurred first. The secondary outcome was all-cause in-hospital mortality. The standard dose was defined as a daily dose of <= 1.5 mg/kg of prednisolone or equivalent, and the high-dose was defined as >= 250 mg of prednisolone or equivalent. Data were analyzed using frequentist and Bayesian logistic models. In addition, a propensity scorematched subgroup was analyzed for the association between high-dose corticosteroid use and adverse outcomes. A total of 1072 patients hospitalized between September 29, 2020, and April 20, 2021, were enrolled in the study. Of these, 188 patients (18%) had a primary outcome; 55 patients (29%) died, and 133 (71%) required invasive mechanical ventilation. Higher age was associated with adverse outcomes in all analyses. Standard dose corticosteroid use was found to be protective (odds ratio [95% confidence interval], 0.53 [0.350.81]) in the final logistic model. Point estimates in the propensity scorematched subgroup did not encourage high-dose corticosteroid use (odds ratio [95% confidence interval], 3.06 [0.989.50]). The posterior probability density distributions generated by the Bayesian logistic model implicated standard-dose corticosteroid use as protective (80% credible intervals, -0.839 to -0.313), whereas it implicated high-dose corticosteroid use as associated with adverse outcomes (80% credible intervals, 0.1630.941). This study found high-dose corticosteroid (>= 250 mg prednisolone daily) use associated with adverse outcomes.
引用
收藏
页数:6
相关论文
共 28 条
[1]   Evaluation of the Current Therapeutic Approaches for COVID-19: A Systematic Review and a Meta-analysis [J].
Abdelrahman, Zeinab ;
Liu, Qian ;
Jiang, Shanmei ;
Li, Mengyuan ;
Sun, Qingrong ;
Zhang, Yue ;
Wang, Xiaosheng .
FRONTIERS IN PHARMACOLOGY, 2021, 12
[2]   URINARY-EXCRETION OF PREDNISOLONE FOLLOWING INTRAVENOUS ADMINISTRATION IN HUMANS [J].
ALHABET, SMH ;
ROGERS, HJ .
JOURNAL OF CLINICAL PHARMACOLOGY, 1989, 29 (10) :922-927
[3]   Guidelines for the Diagnosis and Management of Critical Illness-Related Corticosteroid Insufficiency (CIRCI) in Critically Ill Patients (Part I): Society of Critical Care Medicine (SCCM) and European Society of Intensive Care Medicine (ESICM) 2017 [J].
Annane, Djillali ;
Pastores, Stephen M. ;
Rochwerg, Bram ;
Arlt, Wiebke ;
Balk, Robert A. ;
Beishuizen, Albertus ;
Briegel, Josef ;
Carcillo, Joseph ;
Christ-Crain, Mirjam ;
Cooper, Mark S. ;
Marik, Paul E. ;
Meduri, Gianfranco Umberto ;
Olsen, Keith M. ;
Rodgers, Sophia C. ;
Russell, James A. ;
Van den Berghe, Greet .
CRITICAL CARE MEDICINE, 2017, 45 (12) :2078-2088
[4]   How corticosteroids control inflammation: Quintiles prize lecture 2005 [J].
Barnes, Peter J. .
BRITISH JOURNAL OF PHARMACOLOGY, 2006, 148 (03) :245-254
[5]   brms: An R Package for Bayesian Multilevel Models Using Stan [J].
Buerkner, Paul-Christian .
JOURNAL OF STATISTICAL SOFTWARE, 2017, 80 (01) :1-28
[6]   RETRACTED: A novel approach to managing COVID-19 patients; results of lopinavir plus doxycycline cohort (Retracted Article) [J].
Cag, Yasemin ;
Icten, Sacit ;
Isik-Goren, Burcu ;
Baysal, Naciye Betul ;
Bektas, Begum ;
Selvi, Ece ;
Ergen, Pinar ;
Aydin, Ozlem ;
Ucisik, Ayse Canan ;
Yilmaz-Karadag, Fatma ;
Caskurlu, Hulya ;
Akarsu-Ayazoglu, Tulin ;
Kocoglu, Hasan ;
Uzman, Sinan ;
Nural-Pamukcu, Muge ;
Arslan, Ferhat ;
Bas, Gurhan ;
Kalcioglu, Mahmut Tayyar ;
Vahaboglu, Haluk .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2021, 40 (02) :407-411
[7]   A MECHANISM FOR THE ANTIINFLAMMATORY EFFECTS OF CORTICOSTEROIDS - THE GLUCOCORTICOID RECEPTOR REGULATES LEUKOCYTE ADHESION TO ENDOTHELIAL-CELLS AND EXPRESSION OF ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE-1 AND INTERCELLULAR-ADHESION MOLECULE-1 [J].
CRONSTEIN, BN ;
KIMMEL, SC ;
LEVIN, RI ;
MARTINIUK, F ;
WEISSMANN, G .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (21) :9991-9995
[8]   RECEPTOR-BASED PHARMACOKINETIC PHARMACODYNAMIC ANALYSIS OF CORTICOSTEROIDS [J].
DERENDORF, H ;
HOCHHAUS, G ;
MOLLMANN, H ;
BARTH, J ;
KRIEG, M ;
TUNN, S ;
MOLLMANN, C .
JOURNAL OF CLINICAL PHARMACOLOGY, 1993, 33 (02) :115-123
[9]   Tissue-Specific Immunopathology in Fatal COVID-19 [J].
Dorward, David A. ;
Russell, Clark D. ;
Um, In Hwa ;
Elshani, Mustafa ;
Armstrong, Stuart D. ;
Penrice-Randal, Rebekah ;
Millar, Tracey ;
Lerpiniere, Chris E. B. ;
Tagliavini, Giulia ;
Hartley, Catherine S. ;
Randle, Nadine P. ;
Gachanja, Naomi N. ;
Potey, Philippe M. D. ;
Dong, Xiaofeng ;
Anderson, Alison M. ;
Campbell, Victoria L. ;
Duguid, Alasdair J. ;
Al Qsous, Wael ;
BouHaidar, Ralph ;
Baillie, J. Kenneth ;
Dhaliwal, Kevin ;
Wallace, William A. ;
Bellamy, Christopher O. C. ;
Prost, Sandrine ;
Smith, Colin ;
Hiscox, Julian A. ;
Harrison, David J. ;
Lucas, Christopher D. .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (02) :192-201
[10]   Intravenous methylprednisolone pulse as a treatment for hospitalised severe COVID-19 patients: results from a randomised controlled clinical trial [J].
Edalatifard, Maryam ;
Akhtari, Maryam ;
Salehi, Mohammadreza ;
Naderi, Zohre ;
Jamshidi, Ahmadreza ;
Mostafaei, Shayan ;
Najafizadeh, Seyed Reza ;
Farhadi, Elham ;
Jalili, Nooshin ;
Esfahani, Masoud ;
Rahimi, Besharat ;
Kazemzadeh, Hossein ;
Aliabadi, Maedeh Mahmoodi ;
Ghazanfari, Tooba ;
Sattarian, Mohammadreza ;
Louyeh, Hourvash Ebrahimi ;
Raeeskarami, Seyed Reza ;
Jamalimoghadamsiahkali, Saeidreza ;
Khajavirad, Nasim ;
Mahmoudi, Mahdi ;
Rostamian, Abdolrahman .
EUROPEAN RESPIRATORY JOURNAL, 2020, 56 (06)